{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:50:13Z","timestamp":1773935413847,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006062","name":"Foundation for Promotion of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K15564"],"award-info":[{"award-number":["23K15564"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.resinv.2025.101349","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T06:39:08Z","timestamp":1766126348000},"page":"101349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The risk of recurrence in pathological stage II-IIIA non-small cell lung cancer without lymph node metastasis"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2464-6717","authenticated-orcid":false,"given":"Ryusuke","family":"Sumiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuo","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1956-0708","authenticated-orcid":false,"given":"Mariko","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aritoshi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Takamochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2025.101349_bib1","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group","volume":"26","author":"Pignon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.resinv.2025.101349_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.resinv.2025.101349_bib3","unstructured":"Rami-Porta R, Nishimura KK, Giroux DJ, Detterbeck F, Cardillo G, Edwardset JG, al. The international association for the study of lung cancer lung cancer staging project: proposals for revision of the TNM stage groups in the forthcoming (ninth) edition of the TNM classification for lung cancer."},{"key":"10.1016\/j.resinv.2025.101349_bib4","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/JTO.0000000000000678","article-title":"The international association for the study of lung cancer lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer","volume":"10","author":"Asamura","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.resinv.2025.101349_bib5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/JTO.0b013e3181c814e7","article-title":"Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the lung adjuvant cisplatin evaluation","volume":"5","author":"Douillard","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.resinv.2025.101349_bib6","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1158\/0008-5472.CAN-05-0331","article-title":"Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp","volume":"65","author":"Nagai","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.resinv.2025.101349_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejcts.2003.11.033","article-title":"Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 non-small-cell lung cancer","volume":"25","author":"Gabor","year":"2004","journal-title":"Eur J Cardio Thorac Surg"},{"key":"10.1016\/j.resinv.2025.101349_bib8","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1378\/chest.10-0185","article-title":"Vascular invasion is a strong prognostic factor after complete resection of node-negative non-small cell lung cancer","volume":"138","author":"Naito","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2025.101349_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.lungcan.2007.01.019","article-title":"Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy","volume":"56","author":"Tsuchiya","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2025.101349_bib10","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/1097-0142(19940215)73:4<1177::AID-CNCR2820730409>3.0.CO;2-0","article-title":"Blood vessel invasion and expression of sialyl Lewisx and proliferating cell nuclear antigen in stage I non-small cell lung cancer. Relation to postoperative recurrence","volume":"73","author":"Ogawa","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.resinv.2025.101349_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJMoa2304594","article-title":"Overall survival with Osimertinib in resected EGFR-mutated NSCLC","volume":"389","author":"Tsuboi","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2025.101349_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104010","article-title":"Efficacy and safety of adjuvant EGFR TKI alone and in combination with chemotherapy for resected EGFR mutation-positive non-small cell lung cancer: a Bayesian network meta-analysis","volume":"186","author":"Cui","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.resinv.2025.101349_bib13","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","article-title":"Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial","volume":"398","author":"Felip","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2025.101349_bib14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.annonc.2023.07.001","article-title":"Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial","volume":"34","author":"Felip","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.resinv.2025.101349_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezae110","article-title":"Perioperative immune checkpoint blockades improve prognosis of resectable non-small cell lung cancer","volume":"65","author":"Tian","year":"2024","journal-title":"Eur J Cardio Thorac Surg"},{"key":"10.1016\/j.resinv.2025.101349_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezad383","article-title":"Is underutilization of adjuvant therapy in resected non-small-cell lung cancer associated with socioeconomic disparities?","volume":"64","author":"Rodriguez-Quintero","year":"2023","journal-title":"Eur J Cardio Thorac Surg"},{"key":"10.1016\/j.resinv.2025.101349_bib17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s40425-019-0805-8","article-title":"Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors","volume":"7","author":"Das","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.resinv.2025.101349_bib18","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1200\/JCO.2004.05.063","article-title":"American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer","volume":"22","author":"Benson","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.resinv.2025.101349_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/bju.13683","article-title":"Long-term utility of adjuvant hormonal and radiation therapy for patients with seminal vesicle invasion at radical prostatectomy","volume":"120","author":"Moschini","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.resinv.2025.101349_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.breast.2013.11.007","article-title":"High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in luminal B HER2 negative and node-positive breast cancer","volume":"23","author":"Criscitiello","year":"2014","journal-title":"Breast"},{"key":"10.1016\/j.resinv.2025.101349_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12885-020-6621-1","article-title":"Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.resinv.2025.101349_bib22","article-title":"Real-world study of disease-free survival & patient characteristics associated with disease-free survival in early-stage non-small cell lung cancer: a retrospective observational study","volume":"36","author":"Shah","year":"2023","journal-title":"Cancer Treat Res Commun"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525002047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525002047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:45:11Z","timestamp":1773927911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534525002047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2212534525002047"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2025.101349","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The risk of recurrence in pathological stage II-IIIA non-small cell lung cancer without lymph node metastasis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2025.101349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101349"}}